On May 12, 2026, Global Business Travel Group, Inc. (the “ Company ”) announced that the employment of Mr. John David Thompson, the Company’s EVP, Chief Technology Officer, will terminate on May 31, 2026 (the “ Departure Date ”).
Effective April 30, 2026, T. Benjamin Jennings will no longer serve as Chief Executive Officer of Panamera Holdings Corporation (collectively, the “Company”).
Departed
Edward Hatfield
Board Member
X1 Capital Inc.
Effective
2026-05-12
Filed
May 12, 2026, 2:12 PM ET
Concurrent with this, Edward Hatfield stepped down as a Board Member.
Susan Riel will retire as President and Chief Executive Officer of the Company and the Bank, with her last day of service being July 5, 2026, while remaining a director of the Company and the Bank if she is re-elected to the Company board at the upcoming Annual Meeting.
Thomas Smith, M.D., Executive Vice President and Chief Medical Officer of the Company will depart from his positions at the Company following a transition period during which the Company will conduct a search for his successor.
Departed
Scott Dreyer
Executive Vice President and Chief Commercial Officer
Scott Dreyer, Executive Vice President and Chief Commercial Officer of the Company will depart from his positions at the Company effective August 30, 2026.
On May 12, 2026, the Company announced that Erik Johnson, the Company’s Chief Strategy Officer, resigned from his role as Chief Strategy Officer of the Company effective as of May 11, 2026 and transitioned to a non-executive employee role.
In addition, Mr. Go resigned from the Board and agreed that any position or role he had as an agent, officer or director of the Company, its predecessors, its subsidiaries or its affiliates, will end, in each case, effective as of the Separation Date.
On May 11, 2026, the Company and Mr. Go reached a mutually agreeable arrangement and entered into a Separation and Release Agreement (the “ Separation Agreement ”). Under this agreement, Mr. Go’s last day of employment with the Company was May 11, 2026 (the “ Separation Date ”).
On May 8, 2026, Stephen Curley, Chief Banking Officer for National Business Lines of Western Alliance Bancorporation, provided notice of his resignation in order to pursue another employment opportunity as Chief Executive Officer within the financial services industry.
On May 7, 2026, Dinesh Kumar, M.D., the Chief Medical Officer of Astrana Health, Inc. (the “Company”), notified the Company of his intention to resign, effective as of June 1, 2026.
Dr. Lu informed the Company that, rather than tendering a resignation for consideration under the Director Resignation Policy, he was voluntarily resigning from the Board of Directors effective immediately.
On May 5, 2026, Aditya Gandhi informed Sonoco Products Company (the “Company”) of his intention to resign from his position as Chief Accounting Officer, effective May 29, 2026.
Mr. Asaf Alperovitz, our Chief Financial Officer, notified SolarEdge Technologies, Inc. (the “Company”) of his intent to step down from his role as Chief Financial Officer to pursue another professional opportunity outside of the industry.
On May 6, 2026, Nathan Sleeper and Cynthia Hostetler each notified the Board of Directors (the "Board") of Resideo Technologies, Inc. (the "Company" or "Resideo") of their intention to resign as directors of the Company, effective upon and subject to consummation of the proposed separation (the "Separation") of the Company's ADI global distribution business, which will operate as ADI Global Distribution Inc. ("ADI").
On May 6, 2026, Nathan Sleeper and Cynthia Hostetler each notified the Board of Directors (the "Board") of Resideo Technologies, Inc. (the "Company" or "Resideo") of their intention to resign as directors of the Company, effective upon and subject to consummation of the proposed separation (the "Separation") of the Company's ADI global distribution business, which will operate as ADI Global Distribution Inc. ("ADI").
On May 8, 2026, Richard Saldanha notified the board of directors (the “Board”) of StoneBridge Acquisition II Corporation (the “Company”), of his resignation as a member of the Board and all committees thereof, effective immediately.
On May 8, 2026, Richard Carleton informed the board of directors (the “Board”) of SHF Holdings, Inc. (the “Company”) of his decision not to be considered for reelection to the Board at the Company’s 2026 annual meeting of stockholders.
On May 5, 2026, Shrikrishna Venkataraman notified authID Inc. (the “Company”) of his resignation as a member of the Board of Directors (the “Board”) and as a member of all committees of the Board, effective immediately.
In connection with the Transaction, Gregory Coleman resigned from the Board and the Audit Committee, the Compensation Committee and the Nominating, Corporate Governance, and Corporate Responsibility Committee of the Board on May 11, 2026, effective as of the Closing Date.
In connection with the Transaction, Jonah Peretti resigned as Chief Executive Officer of the Company and Chairman of the Board on May 11, 2026, effective as of the Closing Date.
On May 10, 2026, Mariam Naficy notified the Board of Directors (the “Board”) of Victoria’s Secret & Co. (the “Company”) of her decision to not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders scheduled for June 11, 2026 (the “Annual Meeting”).
On May 7, 2026, Ann Johnson notified N-able, Inc. (the “Company”) and its Board of Directors (the “Board”) of her decision, effective immediately, to resign from the Board and any committee of the Board on which she serves.
On May 11, 2026, Thompson S. Baker II, President of Vulcan Materials Company (the “Company”), notified the Company that he will retire from such position effective July 15, 2026.
On May 5, 2026, Simon Miller notified Equinix, Inc. (the “Company”) of his planned retirement as Chief Accounting Officer (“CAO”) and Principal Accounting Officer (“PAO”) of the Company, to be effective as of July 31, 2026.
Departed
Daniel Woodland
Senior Vice President and President, Materials Solutions
On May 9, 2026, Entegris, Inc. (the "Company") entered into a Transition Agreement and Release (the “Agreement”) with Daniel Woodland, the Company’s Senior Vice President and President, Materials Solutions, pursuant to which Mr. Woodland will retire from the Company on June 1, 2026 (the "Retirement Date").
On May 6, 2026, Chris Dirckze resigned from the board of directors, the compensation committee and the audit committee of Hall Chadwick Acquisition Corp. (the “ Company ”), effective May 6, 2026 (the “ Resignation ”).
Departed
William H. Martel
Executive Vice President and Chief Technology Officer
On May 6, 2026, William H. Martel, Executive Vice President and Chief Technology Officer of Camden National Corporation (the "Company"), provided notice of his intention to retire from his position, effective July 31, 2026.
On May 8, 2026, Laura Tadvalkar, Ph.D., notified Hemab Therapeutics Holdings, Inc. (the “Company”) of her decision to resign as a member of the Company’s board of directors (the “Board”), effective immediately.
On May 7, 2026, Dr. Ahmad Moradi resigned as Chief Executive Officer of AI Era Corp. (the "Company"), effective immediately on May 7, 2026 (the "Termination Date").
Departed
Joe Cleghorn
Chief Executive Officer
American Cannabis Company, Inc.
Effective
2026-05-08
Successor
James Woodend
Filed
May 11, 2026, 11:04 AM ET
On May 8, Joe Cleghorn stepped down from his role as Chief Executive Officer of AMMJ (the "Company").
at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.
at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.
at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.
at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.
at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.